Results 1 - 10 for Biogen Idec

Biogen Idec - Home
Biogen Idec creates new standards of care in oncology, neurology and immunology. As a global leader in the development, manufacturing, and commercialization of novel therapies ...
http://www.biogenidec.com/
open  pop

Biogen Idec - Careers
Biotech jobs & careers with Biogen Idec, global leader in pharmaceutical biotechnology. Need qualified, talented candidates to fill many jobs & career opportunities available in ...
http://www.biogenidec.com/site/careers.html
open  pop

Biogen Idec - Wikipedia, the free encyclopedia
Biogen Idec, Inc. (NASDAQ: BIIB) is a biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the ...
http://wiki.healthhaven.com/Biogen_Idec
open  pop

Biogen Idec Foundation

http://www.biogen.com/site/home.html
open  pop

Biogen Idec: Information from Answers.com
(NASDAQ (GS):BIIB) Type Public On the web http://www.biogenidec.com Employees 4,300 Employee growth 14.7%
http://www.answers.com/topic/biogen-idec-inc
open  pop

Biogen Idec Inc. | Company News & Executive Profiles - BIIB | BNET
Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Biogen Idec Inc.
http://resources.bnet.com/topic/biogen+idec+inc..html
open  pop

Biogen Idec Careers In Biotechnology

http://www.biogen.com/site/001.html
open  pop

Biogen Idec - Company Profile on LinkedIn
This is the limited version of the Biogen Idec company profile: Join LinkedIn or Sign In to see more information. Biogen Idec creates new standards of care in therapeutic areas ...
http://www.linkedin.com/companies/biogen-idec
open  pop

Biogen Idec
Information on what is happening on MSActivesource and in the world of MS. There is an overview of the site, enabling you to answer your questions about MS the disease, how ...
http://msactivesource.cordovandigital.com/biogen.html
open  pop

Biogen Idec Commences Tender Offer for Facet Biotech
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ:BIIB) announced today that FBC Acquisition Corp., its wholly owned subsidiary, has commenced a tender offer to acquire ...
http://www.businesswire.com/news/google/20090921005732/en
open  pop

Featured Results: